本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Biodesix, Inc.

6.62
+0.620010.33%
成交量:21.36万
成交额:137.98万
市值:5,163.60万
市盈率:-1.18
高:6.75
开:5.95
低:5.91
收:6.00
52周最高:34.40
52周最低:3.44
股本:780.00万
流通股本:339.60万
量比:0.25
换手率:6.29%
股息:- -
股息率:- -
每股收益(TTM):-5.5983
每股收益(LYR):-6.6216
净资产收益率:-219.68%
总资产收益率:-20.81%
市净率:45.37
市盈率(LYR):-1.00

数据加载中...

2024/11/08

SEC问询函

Form CORRESP - Correspondence
2024/11/08

SEC问询函

Form CORRESP - Correspondence
2024/11/01

重要事件披露

Form 8-K - Current report
2024/11/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/25

SEC问询函

Form CORRESP - Correspondence
2024/05/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]